Metropolitan Life Insurance Company (MetLife)’s Fulgent Genetics FLGT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,099
| Closed | -$23.8K | – | 778 |
|
|
2024
Q1 | $23.8K | Sell |
1,099
-245
| -18% | -$5.32K | ﹤0.01% | 1772 |
|
|
2023
Q4 | $38.9K | Hold |
1,344
| – | – | ﹤0.01% | 1580 |
|
|
2023
Q3 | $35.9K | Buy |
1,344
+212
| +19% | +$5.67K | ﹤0.01% | 1579 |
|
|
2023
Q2 | $41.9K | Hold |
1,132
| – | – | ﹤0.01% | 1525 |
|
|
2023
Q1 | $35.3K | Sell |
1,132
-208
| -16% | -$6.49K | ﹤0.01% | 1581 |
|
|
2022
Q4 | $39.9K | Hold |
1,340
| – | – | ﹤0.01% | 1607 |
|
|
2022
Q3 | $51.1K | Hold |
1,340
| – | – | ﹤0.01% | 1449 |
|
|
2022
Q2 | $73.1K | Hold |
1,340
| – | – | ﹤0.01% | 1258 |
|
|
2022
Q1 | $83.6K | Sell |
1,340
-4,339
| -76% | -$271K | ﹤0.01% | 1316 |
|
|
2021
Q4 | $571K | Hold |
5,679
| – | – | 0.01% | 1333 |
|
|
2021
Q3 | $511K | Hold |
5,679
| – | – | 0.01% | 1450 |
|
|
2021
Q2 | $524K | Buy |
5,679
+1,662
| +41% | +$153K | 0.01% | 1493 |
|
|
2021
Q1 | $388K | Hold |
4,017
| – | – | 0.01% | 1575 |
|
|
2020
Q4 | $209K | Buy |
4,017
+752
| +23% | +$39.2K | ﹤0.01% | 1909 |
|
|
2020
Q3 | $131K | Buy |
+3,265
| New | +$131K | ﹤0.01% | 2059 |
|